NCT06095271View on ClinicalTrials.gov

MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC

NAActive, not recruitingINTERVENTIONAL
Enrollment

920

Participants

Timeline

Start Date

February 5, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

May 31, 2027

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DIAGNOSTIC_TEST

serum Neurofilament Filament Light chain (sNfL) monitoring

the intervention consist of a blood draw and providing the sNfL information to the treating physician

Trial Locations (8)

CH-4031

University Hospital Basel, Basel

CH-5001

Kantonsspital Aarau, Aarau

Unknown

Inselspital Bern, Bern

Hôpitaux Universitaires de Genève, Geneva

Centre Hospitalier Universitaire Vaudois, Lausanne

Ospedale Regionale di Lugano, sede Civico, Lugano

Kantonsspital St.Gallen, Sankt Gallen

UniversitätsSpital Zürich, Zurich

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER